Transcatheter Aortic Valve Implantation for Degenerative Aortic Valve Regurgitation Long After Heart Transplantation

Transcatheter aortic valve implantation (TAVI) has become a feasible therapeutic option for the management of high-risk patients with severe degenerative aortic stenosis. Recently it has been extended to high-risk patients with severe aortic regurgitation. Degenerative aortic valve disease is genera...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Annals of thoracic surgery 2013-11, Vol.96 (5), p.1864-1866
Hauptverfasser:	Zanuttini, Davide, MD, Armellini, Ilaria, MD, Bisceglia, Teodoro, MD, Spedicato, Leonardo, MD, Bernardi, Guglielmo, MD, Muzzi, Rodolfo, MD, Proclemer, Alessandro, MD, Livi, Ugolino, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aortic Valve - surgery Aortic Valve Insufficiency - surgery Cardiothoracic Surgery Catheterization Heart Transplantation Heart Valve Prosthesis Implantation - methods Humans Male Postoperative Complications - surgery Severity of Illness Index Surgery Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Transcatheter aortic valve implantation (TAVI) has become a feasible therapeutic option for the management of high-risk patients with severe degenerative aortic stenosis. Recently it has been extended to high-risk patients with severe aortic regurgitation. Degenerative aortic valve disease is generally uncommon in heart transplant recipients. We report the case of a 75-year-old man in whom severe degenerative aortic regurgitation developed 14 years after heart transplantation (HTx). Because of multiple comorbidities and high surgical risk, TAVI was preferred. A 29-mm CoreValve prosthesis (Medtronic Inc, Minneapolis, MN) was successfully implanted using a transfemoral approach.
ISSN:	0003-4975 1552-6259
DOI:	10.1016/j.athoracsur.2013.03.040